Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study
Keyword(s):
Keyword(s):
Keyword(s):
2001 ◽
Vol 167
(9)
◽
pp. 5329-5337
◽
Keyword(s):